|
|
Article: Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY(R) DISCMELT(TM) (aripiprazole).
- Article from:
- PR Newswire
- Article date:
- August 17, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Provides Another ABILIFY Formulation Option for Adults With Schizophrenia or Manic Episodes of Bipolar I Disorder
PRINCETON, N.J. and TOKYO, Aug. 17 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY(R) DISCMELT(TM) (aripiprazole) Orally Disintegrating Tablets, a new oral form of the antipsychotic medication ABILIFY(R) (aripiprazole) that disintegrates rapidly in the mouth. The U.S. Food and Drug Administration (FDA) approved ABILIFY DISCMELT on June 7, 2006.
ABILIFY DISCMELT provides a convenient alternative for adults with schizophrenia or manic episodes associated with ...